Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 3/2019

13.03.2019 | Review

Non-invasive follicular thyroid neoplasm with papillary-like nuclearfeatures (NIFTP): a review and update

verfasst von: Bita Geramizadeh, Zahra Maleki

Erschienen in: Endocrine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The nomenclature “Non-invasive Follicular Neoplasm with Papillary-like Nuclear Features (NIFTP)” was introduced in 2016. While NIFTP differs from classic papillary thyroid carcinoma (PTC) in imaging, cytomorphology, histology, molecular profile, treatment, follow up, outcome, and behavior, it largely overlaps with follicular variant of PTC at imaging and cytomorphology. Herein, we review the literature for better understanding NIFTP, and its impact on patient care.

Methods

The English literature was thoroughly evaluated with the key word of “Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP)”.

Observations

NIFTP presents as a thyroid nodule. On imaging, it is a round-to-oval, well circumscribed mass with solid internal content. Aspirated material shows a microfollicular pattern with focal nuclear features of PTC mostly reported in categories 3–5 of the Bethesda System for Reporting Thyroid Cytology (TBRSTC). NIFTP has decreased risk of malignancy in TBRSTC categories 3–6. Histologic examination of NIFTP reveals an encapsulated neoplasm with follicular pattern and nuclear features of PTC with no capsular or vascular invasion. No papillary structure, atypia, or mitosis is present. In contrast to PTC, only 4% of NIFTP cases harbor a BRAF mutation. Because NIFTP carries an excellent prognosis and indolent behavior, the tumor behavior was changed from malignant to a neoplasm with tumor with extremely indolent behavior. The recommended treatment is lobectomy with no further ablation therapy. Until better understanding of NIFTP, patient’s follow up should be occasionally performed by neck ultrasonography and serum thyroglobulin measurement.

Conclusion

NIFTP carries an excellent prognosis. It is critical for both clinicians and patients to be aware of extremely indolent behavior of NIFTP in order to prevent unnecessary, aggressive treatment.
Literatur
1.
Y.E.S.R. Nikiforov, G. Tallini, Z.W. Baloch, F. Basolo et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2, 1023–1029 (2016)CrossRefPubMedPubMedCentral
2.
G. Tallini, R.M. Tuttle, R.A. Ghossein, The history of the follicular variant of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 102, 15–22 (2017)PubMed
3.
L.D. Thompson, Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod. Pathol. 29, 698–707 (2016)CrossRefPubMed
4.
M.M.M. Jaconi, A.I. Pincelli, V. Giardini, M. Scardilli, A. Smith, G. Fellegara, F. Pagni, The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours. Cytopathology 28, 495–502 (2017)CrossRefPubMed
5.
Z.W.S.R. Baloch, W.C. Faquin, M.G. Papotti, F. Basolo et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology. Cancer Cytopathol. 124, 616–620 (2016)CrossRefPubMed
6.
I.M.T. Amendoeira, M. Sobrinho-Simoes, Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules. Endocr. Relat. Cancer 25, R247–R258 (2018)CrossRefPubMed
7.
D.E.J.X. Range, An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Curr. Opin. Oncol. 30, 1–7 (2018)CrossRefPubMed
8.
J. Liu, B. Singh, G. Tallini et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107, 1255–1264 (2006)CrossRefPubMed
9.
R.J.X. Jug Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: an evidence-based nomenclature change. Pathol. Res. Int. 2017, 1057252 (2017)CrossRef
10.
R.V.A.S. Lloyd, V.A. LiVolsi, P.M. Sadow, A.S. Tischler, R.A. Ghossein, R.M. Tuttle, Y.E. Nikiforov, The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Hum. Pathol. 74, 1–4 (2018)CrossRefPubMed
11.
R.V.O.R. Lloyd, G. Kloppel, J. Rosai. WHO Classification of Tumors of Endocrine Organs. 4th edn. (International Agency for Research on Cancer, Lyon, 2017). p. 66–80
12.
M.R.S.J. Kwon, S.Y. Hahn, Y.L. Oh, J.Y. Kwak, E. Lee, Y. Lim, Histogram analysis of greyscale sonograms to differentiate between the subtypes of follicular variant of papillary thyroid cancer. Clin. Radiol. 73(591), e591–591 e597 (2018)
13.
G.C.H.F. Yang, KO, Pathologic basis of the sonographic differences between thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Ultrasonography 37, 157–163 (2018)CrossRefPubMed
14.
S.Y.S.J. Hahn, Y.L. Oh, T.H. Kim, Y. Lim, J.S. Choi, Role of ultrasound in predicting tumor invasiveness in follicular variant of papillary thyroid carcinoma. Thyroid 27, 1177–1184 (2017)CrossRefPubMed
15.
S.A.S. Mahajan, N. Kocheri, D. Jain, S.R. Mathur, V.K. Iyer, Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a comparative study with similar patterned papillary thyroid carcinoma variants. Cytopathology 29, 233–240 (2018)CrossRefPubMed
16.
J.B.C.M. Chandler, M.L. Prasad, G.G. Callender, C. Quinn, D. Chhieng, A.J. Adeniran, Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: implications for patient management. Cancer Cytopathol. 125, 865–875 (2017)CrossRefPubMed
17.
F.M.F. Maletta, L. Torregrossa, E. Duregon, G.P. Casadei et al. Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology. Hum. Pathol. 54, 134–142 (2016)CrossRefPubMed
18.
G.C.H.F.K. Yang, T. Scognamiglio, Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: a Review of 179 Cases. Diagn. Cytopathol. 45, 533–541 (2017)CrossRefPubMed
19.
T.C.Z.F. Brandler, C.Z. Liu, M. Cho, R.P. Lau, A. Simsir, K.N. Patel, W. Sun, Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration? Cancer Cytopathol. 125, 378–388 (2017)CrossRefPubMed
20.
J.F.A.E. Krane, E.S. Cibas, J.A. Barletta, Coming to terms with NIFTP: a provisional approach for cytologists. Cancer Cytopathol. 124, 767–772 (2016)CrossRefPubMed
21.
B.E.C.S. Howitt, M. Eszlinger, R. Paschke, M.G. Drage, J.F. Krane, J.A. Barletta, Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am. J. Clin. Pathol. 144, 850–857 (2015)CrossRefPubMed
22.
T.M.M. Bizzarro, S. Capodimonti, P. Straccia, C.P. Lombardi, A. Pontecorvi, L.M. Larocca, E.D. Rossi, Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer Cytopathol. 124, 699–710 (2016)CrossRefPubMed
23.
H.B.Z. Zhou, R. Nayar, T. Bizzarro, G. Fadda et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Cancer Cytopathol. 126, 20–26 (2018)CrossRefPubMed
24.
W.C.W.L. Faquin, A.H. Afrogheh, S.Z. Ali, J.A. Bishop et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 124, 181–187 (2016)CrossRefPubMed
25.
R.P.P.J. Lau, T.C. Brandler, C.Z. Liu, A. Simsir, F. Zhou, Impact of the Reclassification of “Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma” to “Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features” on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution’s Experience. Am. J. Clin. Pathol. 149, 50–54 (2017)CrossRefPubMed
26.
A.K.S. Bychkov, S. Agarwal, D. Jain, C.K. Jung et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology 50, 411–417 (2018)CrossRefPubMed
27.
W.S.A. Li, M. Lew, J. Pang, X. Jing, Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN. Diagn. Cytopathol. 46, 148–153 (2018)CrossRefPubMed
28.
J.F.W.W. Hang, A.G. Zhou, D.S. Cooper, S.Z. Ali, The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories. Cancer Cytopathol. 126, 309–316 (2018)CrossRefPubMed
29.
E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27, 1341–1346 (2017)CrossRefPubMed
30.
K.P.S.A. du Jour, A.Y. Chen, C.C. Griffith, Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC. Endocr. Pathol. 29, 35–42 (2018)CrossRefPubMed
31.
Y.P.B.J. Hung, A user’s guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Histopathology 72, 53–69 (2018)CrossRefPubMed
32.
K.E.-N.A. Kakudo, S.P. Hodak, E. Khanafshar, Y.E. Nikiforov, V. Nose, L.D.R. Thompson, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in thyroid tumor classification. Pathol. Int. 68, 327–333 (2018).CrossRefPubMed
33.
L.D.R.P.D. Thompson, K. Kakudo, R. Burchette, Y.E. Nikiforov, R.R. Seethala, An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: a Validation Study. Endocr. Pathol. 29, 242–249 (2018).CrossRefPubMed
34.
D.N.N.Y. Poller, Non-invasive follicular thyroid neoplasm with papillary-like nuclei: reducing overtreatment by reclassifying an indolent variant of papillary thyroid cancer. J. Clin. Pathol. 69, 947–948 (2016).CrossRef
35.
R.R.B.Z. Seethala, J.A. Barletta, E. Khanafshar, O. Mete et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod. Pathol. 31, 39–55 (2018)CrossRefPubMed
36.
G.P.M. Arnoux, “Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features” With Focal Spindle Cell Metaplasia. Int. J. Surg. Pathol. 26, 261–265 (2018)CrossRefPubMed
37.
M.R.A.A. Haroon Al Rasheed, G. Tarjan, Encapsulated follicular variant of papillary thyroid carcinoma/noninvasive follicular thyroid neoplasm with papillary-like nuclear features with Spindle Cell Metaplasia: case report and review of literature. Pathol. Res. Pract. 213, 416–421 (2017)CrossRefPubMed
38.
K.C.H.B. Strickland, J.A. Barletta, E.S. Cibas, J.F. Krane, Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a retrospective analysis of atypical and suspicious nodules. Cancer Cytopathol. 126, 86–93 (2018)CrossRefPubMed
39.
Z.W.H.R. Baloch, E.M. Brett, G. Randolph, J.R. Garber, A.E.S.S. Committee, C. Thyroid Scientific, American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Commentary: Managing Thyroid Tumors Diagnosed as Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Endocr. Pract. 23, 1150–1155 (2017)CrossRefPubMed
40.
B.T.G. Xu, T. Scognamiglio, B.R. Roman, R.M. Tuttle, R.A. Ghossein, Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid 27, 512–517 (2017)CrossRefPubMedPubMedCentral
41.
M. Rivera, J. Ricarte-Filho, J. Knauf et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod. Pathol. 23, 1191–1200 (2010)CrossRefPubMedPubMedCentral
42.
B.E. Howitt, Y. Jia, L.M. Sholl, J.A. Barletta, Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid 23, 1256–1262 (2013)CrossRefPubMed
43.
L. Zhao, D. Dias-Santagata, P.M. Sadow, W.C. Faquin, Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol. 125, 323–331 (2017)CrossRefPubMed
44.
V.A. Paulson, P. Shivdasani, T.E. Angell et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of “Carcinomas” Harboring RAS Mutations. Thyroid 27, 506–511 (2017)CrossRefPubMed
45.
D.C.N. Ng, Z.V. Ma, A. van Zante, B. Ljung, E. Khanafshar, Cytomorphologic features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a comparison with infiltrative follicular variant of papillary thyroid carcinoma. J. Basic Clin. Med. 6, 51–56 (2017)CrossRef
46.
M. Afkhami, A. Karunamurthy, S. Chiosea et al. Histopathologic and clinical characterization of thyroid tumors carrying the BRAF(K601E) mutation. Thyroid 26, 242–247 (2016)CrossRefPubMed
47.
K.C.E.M. Strickland, R. Paschke, T.E. Angell, E.K. Alexander et al. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocr. Pathol. 29, 68–74 (2018)CrossRefPubMed
48.
M. Vivero, S. Kraft, J.A. Barletta, Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid 23, 273–279 (2013)CrossRefPubMed
49.
F.M.E. Basolo, C. Ugolini, D.N. Polle, Z. Baloch, The Molecular Landscape of Noninvasive Follicular Thyroid Neoplasm With Papillary-like Nuclear Features (NIFTP): a literature review. Adv. Anat. Pathol. 24, 252–258 (2017)CrossRefPubMed
50.
N.D.M. Borrelli, C. Ugolini, A.M. Poma, M. Miccoli, P. Vitti, P. Miccoli, F. Basolo, miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas. Mod. Pathol. 30, 39–51 (2017)CrossRefPubMed
51.
X.S.H.G. Jiang, M.B. Datto, Young investigator challenge: molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Cancer Cytopathol. 124, 893–900 (2016)CrossRefPubMed
52.
T.H.L.M. Kim, A.Y. Kwon, J.H. Choe, J.H. Kim et al. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Histopathology 72, 648–661 (2018)CrossRefPubMed
53.
R.C.D.M. Jug, X.S. Jiang, Molecular testing for indeterminate thyroid nodules: performance of the Afirma gene expression classifier and ThyroSeq panel. Cancer Cytopathol. 126, 471–480 (2018).CrossRefPubMed
54.
Z.T.S.P. Sahli, C.B. Umbricht, M.A. Zeiger, Preoperative molecular markers in thyroid nodules. Front Endocrinol. 9, 179 (2018)CrossRef
55.
G.V.M. Acquaviva, A. Repaci, K.J. Rhoden, D. de Biase, A. Pession, T. Giovanni, Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance. Histopathology 72, 6–31 (2018)CrossRefPubMed
56.
G.P.O. Fu, C. MacMillan, R. Ralhan, P.G. Walfish, Programmed Death-Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features. EBio Med. 18, 50–55 (2017)
57.
B.R.A.E. Haugen, K.C. Bible, G.M. Doherty, S.J. Mandel et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedPubMedCentral
58.
B.R.S.A. Haugen, E.K. Alexander, K.C. Bible, P. Caturegli et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 27, 481–483 (2017)CrossRefPubMed
59.
A.A.R.H. Ghuzlan, M. Schlumberger, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Curr. Opin. Endocrinol. Diabetes Obes. 24, 377–380 (2017)CrossRefPubMed
60.
P.W. Rosario, Long-Term Outcomes of Patients with Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) > / = 4 cm Treated Without Radioactive Iodine. Endocr. Pathol. 28, 367–368 (2017)CrossRefPubMed
61.
Z.J.S. Aburjania, C. Montemayor-Garcia, R.V. Lloyd, D.F. Schneider, R.S. Sippel, H. Chen, D.M. Elfenbein, Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign? J. Surg. Res. 216, 138–142 (2017)CrossRefPubMedPubMedCentral
62.
V.A.F.K.K. Alves, V. LiVolsi, R.V. Lloyd, Y.E. Nikiforov, V. Nose, M. Papotti, L.D.R. Thompson, Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): Achieving Better Agreement By Refining Diagnostic Criteria. Clin. (Sao Paulo). 73, e576 (2018)CrossRef
Metadaten
Titel
Non-invasive follicular thyroid neoplasm with papillary-like nuclearfeatures (NIFTP): a review and update
verfasst von
Bita Geramizadeh
Zahra Maleki
Publikationsdatum
13.03.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01887-z

Weitere Artikel der Ausgabe 3/2019

Endocrine 3/2019 Zur Ausgabe

Original Article

Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes

Research Letter

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents

Original Article

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer

Original Article

Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function

Original Article

Enhanced hepatic cholesterol accumulation induced by maternal betaine exposure is associated with hypermethylation of CYP7A1 gene promoter

Original Article

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise